Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, discusses the importance of working with physicians to make sure they're comfortable prescribing biosimilars.
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, discusses the importance of working with physicians to make sure they're comfortable prescribing biosimilars.
Transcript
How important is it to collaborate with physicians to make sure they are comfortable prescribing biosimilars and alleviate some of the concerns they might have?
There’s still an educational gap, I think, about biosimilars. It’s still a very new product on the oncology market. We have to understand that biologics are inherently complicated to make, so we have to be comfortable about them being made the same way regardless of who is manufacturing them. We are comfortable with the current therapeutics that are out there.
There will be more coming. How exactly we do it operationally is a challenge, whether we’re changing patients, new starts, each of these drugs is a different drug so we have to have a care plan or a regimen plan that includes those. So, there’s some operational characteristics that have to be worked out, and we’re working through those at OneOncology practices.
For the physicians, there’s still an educational component, and for the patients. Although really, patients have been very comfortable with making a therapeutic switch when their doctor explains to them that they’re getting a drug that’s just like the other drug. It’s not a generic but it’s analogous to a generic. Generics are only for small molecules. Biosimilars are for biologics, and they’re slightly different.
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Getting to Know Dr Fabiola Molina, Hospitalist
February 26th 2024Fabiola Molina, MD, MHS, is a practicing hospitalist and assistant professor of medicine at Yale School of Medicine and Yale New Haven Hospital. An immigrant from Mexico, her experiences straddling 2 worlds, while attempting to navigate with her family the complicated safety-net system for health care in Texas, were key influences to her ardent focus on health equity.
Read More
Kathy Oubre on Strategies to Mitigate Challenges When Adopting New Payment Models
February 23rd 2024While adopting new payment models can come with challenges, there are strategies that can help oncology practices optimize their approaches, said Kathy Oubre, MS, CEO of Pontchartrain Cancer Center.
Read More